ID
28965
Description
Study part: Slitlamp Examination Month 3.A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration.
Keywords
Versions (1)
- 2/18/18 2/18/18 -
Copyright Holder
Roche
Uploaded on
February 18, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Slitlamp Examination Month 3 rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2598g
Slitlamp Examination Month 3
- StudyEvent: ODM
Description
FINDINGS OF INFLAMMATION RIGHT EYE
Alias
- UMLS CUI-1
- C0243095
- UMLS CUI-2
- C0021368
- UMLS CUI-3
- C0229089
Description
Aqueous Cell
Data type
integer
Description
Aqueous Flare
Data type
integer
Alias
- UMLS CUI [1]
- C0262779
Description
Vitreous Cell
Data type
integer
Alias
- UMLS CUI [1]
- C3469499
Description
Vitreous Hemorrhage
Data type
integer
Alias
- UMLS CUI [1]
- C0042909
Description
Posterior Vitreous Detachment
Data type
text
Alias
- UMLS CUI [1]
- C0423361
Description
FINDINGS OF INFLAMMATION LEFT EYE
Alias
- UMLS CUI-1
- C0243095
- UMLS CUI-2
- C0021368
- UMLS CUI-3
- C0229090
Description
Aqueous Cell
Data type
integer
Description
Aqueous Flare
Data type
integer
Alias
- UMLS CUI [1]
- C0262779
Description
Vitreous Cell
Data type
integer
Alias
- UMLS CUI [1]
- C3469499
Description
Vitreous Hemorrhage
Data type
integer
Alias
- UMLS CUI [1]
- C0042909
Description
Posterior Vitreous Detachment
Data type
text
Alias
- UMLS CUI [1]
- C0423361
Similar models
Slitlamp Examination Month 3
- StudyEvent: ODM
C2986440 (UMLS CUI [1,2])
C0021368 (UMLS CUI-2)
C0229089 (UMLS CUI-3)
C0021368 (UMLS CUI-2)
C0229090 (UMLS CUI-3)